Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Marimed (MRMD) Operating Income (2016 - 2025)

Marimed has reported Operating Income over the past 15 years, most recently at -$4.5 million for Q4 2025.

  • Quarterly Operating Income fell 208.24% to -$4.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$2.6 million through Dec 2025, down 192.36% year-over-year, with the annual reading at -$2.8 million for FY2025, 208.09% down from the prior year.
  • Operating Income was -$4.5 million for Q4 2025 at Marimed, down from $1.6 million in the prior quarter.
  • Over five years, Operating Income peaked at $12.0 million in Q2 2021 and troughed at -$4.5 million in Q4 2025.
  • The 5-year median for Operating Income is $2.8 million (2022), against an average of $3.1 million.
  • Year-over-year, Operating Income skyrocketed 598.68% in 2021 and then crashed 208.24% in 2025.
  • A 5-year view of Operating Income shows it stood at $1.2 million in 2021, then surged by 156.77% to $3.1 million in 2022, then decreased by 21.95% to $2.4 million in 2023, then crashed by 160.89% to -$1.5 million in 2024, then crashed by 208.24% to -$4.5 million in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Operating Income are -$4.5 million (Q4 2025), $1.6 million (Q3 2025), and $1.1 million (Q2 2025).